Advanced Search
Contact | Corporate | Help

Ph II Bevacizumab + Etoposide for Pts w Recurrent MG

Sponsors:
  • Duke University
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Glioblastoma
  • Gliosarcoma
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Bevacizumab and Etoposide
Enrollment:
59

Additional information about NCT00612430.


SourceSolution © 2008-2012